-->
search
› › Wockhardt Rises On US FDA Nod For Cancer Drug Decitabine
Wockhardt Rises On US FDA Nod For Cancer Drug Decitabine

Wockhardt Rises On US FDA Nod For Cancer Drug Decitabine

By Wednesday, April 10, 2019 Comment Edit
Wockhardt's Decitabine Injection is a generic version of Dacogen, marketed in USA and other countries by Otsuka.

from NDTV Profit - Latest http://bit.ly/2IcA5Uw

0 Response to "Wockhardt Rises On US FDA Nod For Cancer Drug Decitabine"

Post a Comment

Subscribe to: Post Comments (Atom)

Ads on article

Advertise in articles 1

advertising articles 2

Advertise under the article